- Home
- PNBK vs SPRO Comparison
PNBK vs SPRO Comparison
Compare PNBK & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNBK
- SPRO
- Stock Information
- Founded
- PNBK 1999
- SPRO 2013
- Country
- PNBK United States
- SPRO United States
- Employees
- PNBK N/A
- SPRO N/A
- Industry
- PNBK Major Banks
- SPRO Biotechnology: Pharmaceutical Preparations
- Sector
- PNBK Finance
- SPRO Health Care
- Exchange
- PNBK Nasdaq
- SPRO Nasdaq
- Market Cap
- PNBK 124.5M
- SPRO 128.9M
- IPO Year
- PNBK N/A
- SPRO 2017
- Fundamental
- Price
- PNBK $1.26
- SPRO $2.21
- Analyst Decision
- PNBK
- SPRO Buy
- Analyst Count
- PNBK 0
- SPRO 4
- Target Price
- PNBK N/A
- SPRO $5.00
- AVG Volume (30 Days)
- PNBK 184.5K
- SPRO 450.2K
- Earning Date
- PNBK 11-18-2025
- SPRO 11-13-2025
- Dividend Yield
- PNBK N/A
- SPRO N/A
- EPS Growth
- PNBK N/A
- SPRO N/A
- EPS
- PNBK N/A
- SPRO N/A
- Revenue
- PNBK $15,640,000.00
- SPRO $48,576,000.00
- Revenue This Year
- PNBK N/A
- SPRO N/A
- Revenue Next Year
- PNBK N/A
- SPRO N/A
- P/E Ratio
- PNBK N/A
- SPRO N/A
- Revenue Growth
- PNBK N/A
- SPRO N/A
- 52 Week Low
- PNBK $0.90
- SPRO $0.51
- 52 Week High
- PNBK $7.47
- SPRO $3.22
- Technical
- Relative Strength Index (RSI)
- PNBK 37.54
- SPRO 53.72
- Support Level
- PNBK $1.23
- SPRO $1.84
- Resistance Level
- PNBK $1.35
- SPRO $2.52
- Average True Range (ATR)
- PNBK 0.09
- SPRO 0.12
- MACD
- PNBK 0.00
- SPRO 0.03
- Stochastic Oscillator
- PNBK 20.87
- SPRO 56.62
About PNBK Patriot National Bancorp Inc.
Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.
About SPRO Spero Therapeutics Inc.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.